Psychological aspect of patients with inflammatory bowel disease, which may be related to the quality of life, sleep and disease characteristics

References

• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Ng S, Kaplan GG, Banerjee R, et al. Incidence and phenotype of inflammatory bowel disease from 13 countries in Asia-Pacific: results from the Asia-Pacific Crohn’s and colitis epidemiologic study 2011–2013. Gastroenterol. 2016;150(4):S21.
   Web of Science ®Google Scholar
• Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–727.
   PubMed Web of Science ®Google Scholar
• Burisch J, Jess T, Martinato M, et al. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7(4):322–337.
   PubMed Web of Science ®Google Scholar
• Neuendorf R, Harding A, Stello N, et al. Depression and anxiety in patients with inflammatory bowel disease: a systematic review. J Psychosom Res. 2016;87:70–80.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Hitchon CA, Walld R, et al. Increased burden of psychiatric disorders in inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(2):360–368.
   PubMed Web of Science ®Google Scholar
• Allegretti JR, Borges L, Lucci M, et al. Risk factors for rehospitalization within 90 days in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(11):2583–2589.
   PubMed Web of Science ®Google Scholar
• Navabi S, Gorrepati VS, Yadav S, et al. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(11):2303–2308.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Gainer VS, Perez RG, et al. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn’s disease. Aliment Pharmacol Ther. 2013;37(4):445–454.
   PubMed Web of Science ®Google Scholar
• van den Brink G, Stapersma L, Vlug LE, et al. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2018;48(3):358–369.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Williams CJM, Sood R, et al. Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2017;15(3):376–384.e5.
   PubMed Web of Science ®Google Scholar
• Gracie DJ, Williams CJM, Sood R, et al. Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease. Am J Gastroenterol. 2016;111(4):541–551.
   PubMed Web of Science ®Google Scholar
• Frolkis AD, Vallerand IA, Shaheen A-A, et al. Depression increases the risk of inflammatory bowel disease, which may be mitigated by the use of antidepressants in the treatment of depression. Gut. 2019;68(9):1606–1612.
   PubMed Web of Science ®Google Scholar
• Taft TH, Ballou S, Bedell A, et al. Psychological considerations and interventions in inflammatory bowel disease patient care. Gastroenterol Clin North Am. 2017;46(4):847–858.
   PubMed Web of Science ®Google Scholar
• Lewis K, Marrie RA, Bernstein CN, et al. The prevalence and risk factors of undiagnosed depression and anxiety disorders among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25(10):1674–1680.
   PubMed Web of Science ®Google Scholar
• Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale–preliminary report. Psychopharmacol Bull. 1973;9(1):13–28.
   PubMedGoogle Scholar
• Wang ZY. Symptom checklist 90 (SCL‐90). Shanghai Psychiatry. 1984;2:68–70.
   Google Scholar
• Ware JE, Jr, Sherbourne CD. The MOS 36-item Short-Form health survey (SF36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483.
   PubMed Web of Science ®Google Scholar
• Li L, Wang H, Shen Y. Chinese SF-36 health survey: translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health. 2003;57(4):259–263.
   PubMed Web of Science ®Google Scholar
• Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96(3):804–810.
   PubMed Web of Science ®Google Scholar
• Ren WH, Lai M, Chen Y, et al. Validation of the mainland Chinese version of the inflammatory bowel disease questionnaire (IBDQ) for ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2007;13(7):903–910.
   PubMed Web of Science ®Google Scholar
• Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
   PubMed Web of Science ®Google Scholar
• Tsai PS, Wang SY, Wang MY, et al. Psychometric evaluation of the Chinese version of the Pittsburgh sleep quality index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 2005;14(8):1943–1952.
   PubMed Web of Science ®Google Scholar
• Inflammatory Bowel Disease Group, Chinese Society of Gastroenterology, Chinese Medical Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing). J Dig Dis. 2021;22(6):298–317.
   PubMed Web of Science ®Google Scholar
• Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–136.
   PubMed Web of Science ®Google Scholar
• Ng JY, Chauhan U, Armstrong D, et al. A comparison of the prevalence of anxiety and depression between uncomplicated and complex IBD patient groups. Gastroenterol Nurs. 2018;41(5):427–435.
   PubMed Web of Science ®Google Scholar
• Walker JR, Ediger JP, Graff LA, et al. The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. Am J Gastroenterol. 2008;103(8):1989–1997.
   PubMed Web of Science ®Google Scholar
• Kurina LM, Goldacre MJ, Yeates D, et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001;55(10):716–720.
   PubMed Web of Science ®Google Scholar
• Koeter MW. Validity of the GHQ and SCL anxiety and depression scales: a comparative study. J Affect Disord. 1992;24(4):271–279.
   PubMed Web of Science ®Google Scholar
• Sgambato D, Miranda A, Ranaldo R, et al. The role of stress in inflammatory bowel diseases. Curr Pharm Des. 2017;23(27):3997–4002.
   PubMed Web of Science ®Google Scholar
• Martin-Subero M, Anderson G, Kanchanatawan B, et al. Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways. CNS Spectr. 2016;21(2):184–198.
   PubMed Web of Science ®Google Scholar
• Abautret-Daly A, Dempsey E, Parra-Blanco A, et al. Gut-brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease. Acta Neuropsychiatr. 2018;30(5):275–296.
   PubMed Web of Science ®Google Scholar
• McCombie AM, Mulder RT, Gearry RB. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis. 2013;7(12):935–949.
   PubMed Web of Science ®Google Scholar
• Ueno F, Nakayama Y, Hagiwara E, et al. Impact of inflammatory bowel disease on Japanese patients’ quality of life: results of a patient questionnaire survey. J Gastroenterol. 2017;52(5):555–567.
   PubMed Web of Science ®Google Scholar
• Knowles SR, Keefer L, Wilding H, et al. Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-Part II. Inflamm Bowel Dis. 2018;24(5):966–976.
   PubMed Web of Science ®Google Scholar
• McColl E, Han SW, Barton JR, et al. A comparison of the discriminatory power of the inflammatory bowel disease questionnaire and the SF-36 in people with ulcerative colitis. Qual Life Res. 2004;13(4):805–811.
   PubMed Web of Science ®Google Scholar
• Guthrie E, Jackson J, Shaffer J, et al. Psychological disorder and severity of inflammatory bowel disease predict health-related quality of life in ulcerative colitis and Crohn’s disease. Am J Gastroenterol. 2002;97(8):1994–1999.
   PubMed Web of Science ®Google Scholar
• Estevinho MM, Afonso J, Rosa I, et al. Placebo effect on the health-related quality of life of inflammatory bowel disease patients: a systematic review with meta-analysis. J Crohns Colitis. 2018;12(10):1232–1244.
   PubMed Web of Science ®Google Scholar
• Michalopoulos G, Vrakas S, Makris K, et al. Association of sleep quality and mucosal healing in patients with inflammatory bowel disease in clinical remission. Ann Gastroenterol. 2018;31(2):211–216.
   PubMed Web of Science ®Google Scholar
• Brooks AJ, Rowse G, Ryder A, et al. Systematic review: psychological morbidity in young people with inflammatory bowel disease risk factors and impacts. Aliment Pharmacol Ther. 2016;44(1):3–15.
   PubMed Web of Science ®Google Scholar
• Hashash JG, Ramos-Rivers C, Youk A, et al. Quality of sleep and coexistent psychopathology have significant impact on fatigue burden in patients with inflammatory bowel disease. J Clin Gastroenterol. 2018;52(5):423–430.
   PubMed Web of Science ®Google Scholar
• Swanson GR, Burgess HJ. Sleep and circadian hygiene and inflammatory bowel disease. Gastroenterol Clin North Am. 2017;46(4):881–893.
   PubMed Web of Science ®Google Scholar
• Shoham S, Davenne D, Cady AB, et al. Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol. 1987;253(1 Pt 2):R142–R149.
   PubMed Web of Science ®Google Scholar
• Ranjbaran Z, Keefer L, Farhadi A, et al. Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol. 2007;22(11):1748–1753.
   PubMed Web of Science ®Google Scholar
• Huppertz-Hauss G, Høivik ML, Elsness-Jørgensen LP, et al. Health-related quality of life in patients with inflammatory bowel disease 20 years after diagnosis: results from the IBSEN study. Inflamm Bowel Dis. 2016;22(7):1679–1687.
   PubMed Web of Science ®Google Scholar
• Mueller R, Ziade F, Pittet V, et al. Quality of life in Swiss paediatric inflammatory bowel disease patients: do patients and their parents experience disease in the same way? J Crohns Colitis. 2016;10(3):269–276.
   PubMed Web of Science ®Google Scholar
• Anderson A, Click B, Ramos-Rivers C, et al. The association between sustained poor quality of life and future opioid use in inflammatory bowel disease. Inflamm Bowel Dis. 2018;24(7):1380–1388.
   PubMed Web of Science ®Google Scholar
• Peppas S, Pansieri C, Piovani D, et al. The brain-gut axis: psychological functioning and inflammatory bowel diseases. J Clin Med. 2021;10(3):377.
   PubMed Web of Science ®Google Scholar
• Gîlc-Blanariu GE, Ștefnescu G, Trifan AV, et al. Sleep impairment and psychological distress among patients with inflammatory bowel disease-beyond the obvious. JCM. 2020;9(7):2304.
   Web of Science ®Google Scholar
• Leone D, Gilardi D, Corrò BE, et al. Psychological characteristics of inflammatory bowel disease patients: a comparison between active and nonactive patients. Inflamm Bowel Dis. 2019;25(8):1399–1407.
   PubMed Web of Science ®Google Scholar
• Craven MR, Quinton S, Taft TH. Inflammatory bowel disease patient experiences with psychotherapy in the community. J Clin Psychol Med Settings. 2019;26(2):119–183.
   Web of Science ®Google Scholar